Skip to main content
PRO MEDICUS LIMITED logo

PRO MEDICUS LIMITED — Investor Relations & Filings

Ticker · PME ISIN · AU000000PME8 LEI · 98450085A903D1BMFF27 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2026-05-17 Board/Management Inform…
Country AU Australia
Listing ASX PME

About PRO MEDICUS LIMITED

https://www.promed.com.au

Pro Medicus Limited provides advanced healthcare imaging software and enterprise-wide IT solutions. The company’s core offering is the Visage 7 platform, which employs server-side rendering technology to enable rapid, high-resolution streaming of medical images, including MRI, CT, and X-ray data. Its product suite encompasses diagnostic viewing, vendor-neutral archiving, and clinical workflow management. Designed for large-scale health systems and academic medical centers, the technology supports cloud-based deployments and integrates artificial intelligence to streamline diagnostic processes. The platform focuses on performance and scalability, allowing clinicians to access and interpret complex imaging datasets from multiple locations without the need for local data transfer.

Recent filings

Filing Released Lang Actions
Resignation Head of Business Operations & Investor Relations 2 pages 411.2KB
Board/Management Information Classification · 85% confidence The document is a company announcement reporting the resignation of the Head of Business Operations and Investor Relations, a senior management change. This fits the definition of a Board/Management Information filing (MANG).
2026-05-17 English
PME signs 7-Year A$90M Deal with Beth Israel Lahey Health 2 pages 181.7KB
Regulatory Filings Classification · 20% confidence The document is a corporate press release announcing a commercial contract award (7-year, A$90M deal) with Beth Israel Lahey Health. It contains no financial statements, no financing or capital structure details, no meeting materials, and no regulatory compliance certificates. It is not an earnings release, interim report, or any other specific category. Therefore, it falls under the fallback category for general regulatory/corporate announcements: RNS.
2026-05-17 English
PME signs 5-year, A$37M contract renewal with Northwestern 2 pages 244.4KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about a contract renewal between Pro Medicus Limited and Northwestern Medicine. It details the terms of a 5-year, A$37 million contract renewal, highlighting increased minimums and fees per transaction. There is no financial report, earnings summary, or detailed financial statements included. The document is relatively short (3050 characters) and focuses on a specific business update related to contract renewal, which aligns with capital or financing activities. Therefore, the document fits best under Capital/Financing Update (CAP).
2026-04-12 English
Becoming a substantial holder 52 pages 5.9MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder' and details the substantial shareholding of State Street Corporation and its subsidiaries in Pro Medicus Limited as of 09/04/2026. It provides detailed information about the number of shares held, voting power, nature of relevant interests, and registered holders. This type of filing is a notification of a major shareholding, specifically indicating when a party becomes a substantial holder by crossing a voting power threshold. There is no financial performance data, management discussion, or other report content. The document is not an announcement of a report but the actual notification of shareholding. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2026-04-12 English
PME signs 5-year, A$23M contract with University of Maryland 2 pages 181.8KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement about Pro Medicus Limited signing a 5-year contract worth A$23M with the University of Maryland Medical System. It details the contract terms, product implementation plans, and includes quotes from the CEO. There are no financial statements, regulatory forms, or detailed financial performance data. The document is an update on a business development or contract signing, which fits the category of Capital/Financing Update (CAP) as it relates to a significant contract and potential revenue stream. The document length is under 5,000 characters and is not a report publication announcement or certification. Therefore, the best classification is CAP with high confidence.
2026-04-07 English
Notification of buy-back - PME 5 pages 15.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3C - Notification of buy-back' and contains detailed information about a buy-back program by Pro Medicus Limited, including the type of buy-back (on-market), number of securities to be bought back, broker details, and key dates. It is a formal announcement related to the company's repurchase of its own shares. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length is 2888 characters, which is consistent with a detailed announcement rather than a brief notice or a full financial report. Therefore, the correct classification is POS with high confidence.
2026-03-31 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.